| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 21 |
| 1 | ETOPOSIDE | 20 |
| 2 | METHOTREXATE SODIUM | 20 |
| 3 | METHOTREXATE | 19 |
| 4 | FLUDARABINE PHOSPHATE | 17 |
| 5 | ANTI ITCH | 13 |
| 6 | ANTI-ITCH | 13 |
| 7 | ANTI-ITCH CREAM | 13 |
| 8 | ANTI-PRURITIC | 13 |
| 9 | ANTIPRURITIC (ANTI-ITCH) | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 1 | 0.0058 |
| 1 | DAUNORUBICIN HYDROCHLORIDE | 6 | 0.0036 |
| 2 | HYDROCORTISONE SODIUM SUCCINATE | 7 | 0.0018 |
| 3 | CAPIVASERTIB | 5 | 0.0016 |
| 4 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 5 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 6 | LOMUSTINE | 2 | 0.0008 |
| 7 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 8 | BRODALUMAB | 1 | 0.0005 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 3 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Actinomycin [EPC] | 1 | 0.0005 |
| 2 | Topoisomerase Inhibitor [EPC] | 20 | 0.0003 |
| 3 | Estrogen Receptor Antagonist [EPC] | 8 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 30 | 0.0001 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |